Accessibility Menu
Danaher logo

Danaher(NYSE) DHR

Current Price$177.87
Market Cap$142.34BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1969)+57,726%
5 Year-17%
1 Year+7%
1 Month+14%
Danaher last closing stock price
MetricPriceDate
Last closeUSD 201.112026-07-20
Danaher stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.47%USD 200.162026-07-13
1 month+13.75%USD 176.802026-06-18
3 month+3.59%USD 194.142026-04-21
Year to date-11.78%USD 227.962025-12-31
1 year+6.6%USD 188.662025-07-18
3 year-9.81%USD 222.982023-07-21
5 year-16.91%USD 242.032021-07-21
Since inception+57,726.13%USD 0.351969-12-10

Danaher Financials at a Glance

Market Cap

$142.34BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$25.11B

Net Income (TTM)

$4.00B

EPS (TTM)

$5.17

P/E Ratio

38.87

Dividend

$1.44

Beta (Volatility)

0.90 (Low)

Price

$177.87

Volume

1,069,258

Open

$168.75

Previous Close

$201.11

Daily Range

$165.75 - $179.25

52-Week Range

$160.93 - $242.80

Estimated Earnings Date

Jul 21, 2026

DHR: Motley Fool Moneyball Superscore

65

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Danaher

Danaher makes tools that help doctors diagnose diseases and scientists study cells. Its water analysis systems help keep drinking water safe. Hospitals, labs, and factories use Danaher’s products to solve daily challenges.

Products and Services

Diagnostics (38.9% of sales in Q2 2025): Devices and tests for hospitals and labs to detect diseases and monitor health.

Environmental Solutions: Water testing and treatment systems for safe drinking water in homes and industries.

Applied Solutions: Instruments for packaging, printing, and product tracking in consumer and industrial markets.

Growth and Expansion

Integrated new product lines and reorganized life sciences businesses in 2025 to address changing customer needs.

Repurchased 4.5 million shares for $1.1 billion in the first half of 2025.

What Makes Danaher Stand Out

The company relies on recurring revenue from consumables and services, making its income more stable. Its focus on continuous improvement and operational efficiency supports long-term competitiveness.

Five Things You Need to Know

Revenue in Q2 2025 was $5.94 billion, up 3.4% from Q2 2024.

Recurring revenue was $4.97 billion in Q2 2025, 83.7% of total sales.

Biotechnology segment sales grew 8.0% year-over-year in Q2 2025.

Operating profit was $760 million in Q2 2025, down 35% from Q2 2024.

Bottom Line

Danaher has evolved into a diversified science and technology company with a global footprint. Recurring revenue and a broad range of products support its position in healthcare and industrial markets.

AI Generated • Apr 16, 2026

Industry

Life Sciences Tools and Services

Employees

60,000

CEO

Rainer M. Blair

Headquarters

Washington, DC 20037-1701, US

DHR Financials

Key Financial Metrics (TTM)

Gross Margin

60.68%

Operating Margin

20.95%

Net Income Margin

14.89%

Return on Equity

7.06%

Return on Capital

7.24%

Return on Assets

4.42%

Earnings Yield

2.57%

Dividend Yield

0.72%

Payout Ratio

24.67%

Stock Overview

Market Cap

$142.34BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

707.77M

Volume

1.07M

Avg. Volume

4.69M

Financials (TTM)

Gross Profit

$14.69B

Operating Income

$5.13B

EBITDA

$6.43B

Operating Cash Flow

$6.64B

Capital Expenditure

-$1.17B

Free Cash Flow

$5.47B

Cash & ST Invst.

$4.35B

Total Debt

$26.56B

Danaher Performance Analysis

Danaher annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 26,643,000,000-9.5%
20232023-12-31USD 23,890,000,000-10.3%
20242024-12-31USD 23,875,000,000-0.1%
20252025-12-31USD 24,568,000,0002.9%
Danaher sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-262.0%
Q42025-12-3113.0%
Q12026-03-27-13.0%
Q22026-06-265.3%
Danaher annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 9.6411.9%
20232023-12-31USD 6.38-33.8%
20242024-12-31USD 5.29-17.1%
20252025-12-31USD 5.05-4.6%
Danaher sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-2664.9%
Q42025-12-3132.3%
Q12026-03-27-13.7%
Q22026-06-26-15.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$6.27B

+5.5%

Gross Profit

$3.61B

-8.7%

Gross Margin

57.64%

N/A

Market Cap

$142.34BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.33M

N/A

Employees

61,000

N/A

Net Income

$870.00M

+56.8%

EBITDA

$1.13B

-15.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$4.35B

+47.0%

Total Debt

$26.56B

+43.1%

Accounts Receivable

$3.97B

-12.2%

Inventory

$3.26B

+21.2%

Long Term Debt

$25.15B

+49.2%

Short Term Debt

$1.41B

-17.1%

Return on Assets

4.42%

N/A

Return on Invested Capital

6.82%

N/A

Free Cash Flow

$1.27B

+16.1%

Operating Cash Flow

$1.53B

+14.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PFEPfizer Inc.
$24.91+0.63%
ISRGIntuitive Surgical, Inc.
$353.06-0.03%
GILDGilead Sciences, Inc.
$130.17-2.28%
SYKStryker Corporation
$315.46-1.15%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$7.59+0.10%
NOKNokia
$10.62+0.05%
AALAmerican Airlines Group
$15.19+0.00%
HLHecla Mining
$15.15+0.06%

Questions About DHR

What is the current price of Danaher?

Danaher is trading at $177.87 per share.

What is the 52-week range for Danaher?

Over the past 52 weeks, Danaher has traded between $160.93 and $242.80.

How much debt does Danaher have?

As of the most recent reporting period, Danaher reported total debt of $19.68B.

How much cash does Danaher have on hand?

Danaher reported $5.70B in cash and cash equivalents in its most recent financial results.

What is Danaher’s dividend yield?

Danaher currently has a dividend yield of 0.72%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.